| 产品描述: | VRAC / ICl的阻滞剂,膨胀;Blocker of VRAC/ICl, swell;产品介绍:DCPIB 是一种选择性、可逆、有效的体积调节性阴离子通道 (VRAC) 抑制剂,能够电压依赖性激活钾离子通道 TREK1 和 TRAAK,抑制 TRESK,TASK1 和 TASK3,IC50 值分别为 0.14,0.95,50.72 μM。DCPIB 同时抑制肿胀激活氯电流 (ICl,swell),在 CPAE 细胞中,IC50 值为 4.1 μM。; |
| 靶点: |
IC50:0.14 μM (TRESK), 0.95 μM (TASK1), 50.72 μM (TASK3), 4.1 μM (ICl,swell, CPAE cells) |
| 体内研究: |
LDN-212854 (脑室内输注,1 mM,10 μL) 抑制 rMCAO 大鼠的小胶质细胞激活并改善神经元损伤。 |
| 参考文献: |
1. Lv J, et al. DCPIB, an Inhibitor of Volume-Regulated Anion Channels, Distinctly Modulates K2P Channels. ACS Chem Neurosci. 2019 Apr 17. 2. Decher N, et al. DCPIB is a novel selective blocker of I(Cl,swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration. Br J Pharmacol. 2001 Dec;134(7):1467-79. 3. Qingdong Han, et al. DCPIB, a potent volume-regulated anion channel antagonist, attenuates microglia-mediated inflammatory response and neuronal injury following focal cerebral ischemia. Brain Res. 2014 Jan 13;1542:176-85. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.34 ml |
11.699 ml |
23.399 ml |
| 5 mM |
0.468 ml |
2.34 ml |
4.68 ml |
| 10 mM |
0.234 ml |
1.17 ml |
2.34 ml |
| 50 mM |
0.047 ml |
0.234 ml |
0.468 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |